Patent · US Active

Clostridium difficile polypeptides as vaccine

US9932374B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Cesira Galeotti · Poggibonsi, IT
Rosanna Leuzzi · Siena, IT
Mariagrazia Pizza · Siena, IT
Maria Scarselli · Siena, IT
Meera Unnikrishnan · Siena, IT
Manuele Martinelli · Siena, IT

Key dates

Filing date	Sep 19, 2013
Grant date	Apr 3, 2018
Priority date	—
Expiry date	Dec 19, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides methods, proteins, nucleic acids and antibodies for preventing or treating a C. difficile infection in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.